about
Lurasidone for the treatment of bipolar depression: an evidence-based reviewA review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach.Lurasidone as a potential therapy for bipolar disorder.Effects of the neurotensin NTS₁ receptor agonist PD149163 on visual signal detection in rats.Lurasidone in schizophrenia: new information about dosage and place in therapy.The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder.Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.Pharmaceuticals that contain polycyclic hydrocarbon scaffolds.
P2860
Q26796437-2C2DA244-74EF-414C-842F-700AF2EA4FEFQ30353864-75D69AC1-5346-4F28-A094-61D4BD9DC145Q37231216-082A1295-DEBE-4CDB-8F17-2DD6F49E7AC5Q37389307-E38C0CB7-63CA-4F48-BA40-0F53F204C138Q38045797-50AE531D-3824-4979-AECD-75EC56BCCB3BQ38208032-11064507-99BA-425C-B91C-4083B18407B8Q38239613-32E8867F-1C62-434D-A178-356300F3E2D3Q38546598-1962A847-91D1-4026-849A-869907E78E87
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lurasidone for schizophrenia: what's different?
@en
Lurasidone for schizophrenia: what's different?
@nl
type
label
Lurasidone for schizophrenia: what's different?
@en
Lurasidone for schizophrenia: what's different?
@nl
prefLabel
Lurasidone for schizophrenia: what's different?
@en
Lurasidone for schizophrenia: what's different?
@nl
P2860
P356
P1476
Lurasidone for schizophrenia: what's different?
@en
P2093
Joshua T Kantrowitz
P2860
P304
P356
10.1586/ERN.12.7
P577
2012-03-01T00:00:00Z